Bull market Hello, can you help me? I started to worry about the world of trading in January 2020 and shortly after when the pandemic started and we were confined it was a very useful and interesting hobby. Since the pandemic began and with the confinement, I took courses on the stock market, I read, searched, informed, understood and learned a lot. MANY have...
Pacific Ethanol doing a reversal up with COVID spike and Ethanol Futures change. Awaiting this going to target $10-11 on short term with another positive earnings and 3rd plant running more to market need. Announcement also selling into more profitable libations market of low calorie seltzers and other consumer driven markets of STAY AT HOME during COVID-19.
If there is an second Virus, which is an diffrent variant of Covid-19, then we will see an drop down to 11000 points for sure. All the Vaccine hype will be over. Stay safe! If not, we will have an stop near to us, but if the yellow line will broke it will go down to the next green line, if this can´t hold drop to the next and so on.
Classic Inverse Head & Shoulders breakout on good volume. 4.16 about to get filled and likely $5+ coming before the week's end. Promo campaign is under way and news of sales and/or uplisting to TSX/NASDAQ is expected.
With the Vaccine soon to be Online this Chart is looking Fantastic. Covid Has put a Hurting on mines and production is gonna be in Full demand The worlds Power plant are in Great need Uranium. So with some Volume Short term and long term Macro Chart Look like they are Warming up double Bottom cup Formation Handel to Lift off like to enter somewhere near 12.60 on volume
MRNA broke out of $100 hitting $178 within 4 days on high volume and multiple gap ups. This is significant evidence of a blow off top. Afterwards, we printed a daily bullish engulfing pattern then corrected upwards for 5 days before printing another daily engulfing pattern. The target is $100, which completes the blow off top move and the 1.618 extension of the...
Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy ● Vaccibody demonstrates promising pre-clinical data with its second-generation COVID-19 vaccine candidate, VB10.COV2 ● VB10.COV2 induces rapid, strong and long-lasting neutralizing antibodies and multifunctional, dominant CD8+ T...
#CRSP CRSP NASDAQ:CVAC SWB:8EM
An interesting trend on BNTX, complete wave II with a clear end of correction on main channel. Wave III is currently underway. Hope you find the chart interesting. Please leave a like or drop your comment below and follow me for more updates. DISCLAIMER: This MUST NOT be taken as a trading signal.
Potential multi-bagger from current levels. Offering testing solutions for schools, airlines, arenas, stadiums, etc. Under $10M mkt cap with comparables trading at 5x to 10x.
BIOV.C may have found a bottom at ~ .19 after filling the gap with insiders recently buying at over .30. Approaching oversold area on the Daily chart.
The wealthy Might need to go to space to make up for all the traveling they missed can't see this doing bad even in a economic downturn the rich have even more money now then before Covid. Like The Cup and Hope for A consolidation Reset to Form handle Then Break with Enough Power to get Through the Resistance on volume.. Depth of cup is about 7.50 so look for a...
My last chart: November 22, 2020: Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA (The Motley Fool). Regeneron Covid Drug Gets Emergency OK. Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. (the street). If you are interested...
ZM is gearing up for a good move ahead of their earnings report November 30. Currently flagging, it is looking to clear a 419 resistance + breakout before pushing up to its next resistance around 446 to 451. If it can clear this level, it may attempt to fill the gap (modestly at the next resistance 477.50, or aggressively at 482.50). Ahead of their earnings, and...